CPT code 30120 denotes surgical excision or abrasion of diseased nasal skin tissue due to rhinophyma, a condition that produces hypertrophic, thickened skin and enlarged sebaceous glands on the nose. Nationally, this code captures procedures that address both functional and cosmetic sequelae of advanced rosacea-related tissue overgrowth and is relevant for surgical specialists, facility billing, and payer coverage policy. Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, common sites of service, and what to expect in billing and claims handling for this service line. The publication outlines typical billing considerations, common modifiers reported with this service, and the clinical indications that justify surgical intervention. It also highlights benchmarking elements and policy updates that affect coverage and documentation expectations for reconstructive or debulking procedures of the nose. Data not available in the input is noted where specific payer policies, related ICD-10 codes, and associated taxonomies are not provided.